For example, differential FGFR3 expression has been associated with various malignancies, including bladder cancer and multiple myeloma, where overexpression or activating mutations in FGFR3 contribute to tumor growth and progression [33–35]. This evidence concerns the gene FGFR3 and neoplasm.